EWSR1 and Ewing sarcoma: Despite apparent immunogenicity in a study of EWS-FLI1 consolidative immunotherapy [9], Ewing sarcoma vaccines against EWS peptides or mRNA coding for EWS peptides have not become part of standard-of-care or are not in clinical trials yet.